{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:36:52Z","timestamp":1783676212714,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.urology.2023.02.044","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T18:52:22Z","timestamp":1679770342000},"page":"74-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin\u00a0Drug Shortage"],"prefix":"10.1016","volume":"177","author":[{"given":"Brian","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2023.02.044_bib1","first-page":"1021","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2023.02.044_bib2","first-page":"2158","article-title":"A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the international bladder cancer group","volume":"186","author":"Brausi","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2023.02.044_bib3","first-page":"1","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update","volume":"9","author":"Guallar-Garrido","year":"2020","journal-title":"ImmunoTargets\u00a0Ther"},{"key":"10.1016\/j.urology.2023.02.044_bib4","first-page":"1189","article-title":"Intravesical therapy for the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis","volume":"197","author":"Chou","year":"2017","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2023.02.044_bib5","first-page":"481","article-title":"Manufacturing and the market: rationalizing the shortage of Bacillus Calmette-Gu\u00e9rin","volume":"4","author":"Bandari","year":"2018","journal-title":"Eur\u00a0Urol\u00a0Focus"},{"key":"10.1016\/j.urology.2023.02.044_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/BLC-179018","article-title":"The BCG shortage","volume":"3","author":"Messing","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urology.2023.02.044_bib7","series-title":"The\u00a0Washington\u00a0Post","article-title":"Low prices of some lifesaving drugs make them impossible to get","author":"McGinley","year":"2019"},{"key":"10.1016\/j.urology.2023.02.044_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: a global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.urology.2023.02.044_bib9","first-page":"1","article-title":"Critical shortage in BCG immunotherapy: how did we get here and where will it take us?","volume":"40","author":"Harvey","year":"2022","journal-title":"Urol\u00a0Oncol: Semin\u00a0Orig\u00a0Investig"},{"key":"10.1016\/j.urology.2023.02.044_bib10","unstructured":"Merck to Construct New Facility in the United States to Expand Manufacturing Capacity for TICE\u00ae BCG [press release]. January 27, 2021."},{"key":"10.1016\/j.urology.2023.02.044_bib11","first-page":"315","article-title":"Prognostic impact of Bacillus Calmette-Gu\u00e9rin interruption at the time of induction and consolidation","volume":"9","author":"Alhogbani","year":"2017","journal-title":"Urol\u00a0Ann"},{"key":"10.1016\/j.urology.2023.02.044_bib12","unstructured":"BCG Shortage Info - October 2020 Announcement about BCG Production, Supply: American Urological Association.\u00a02020 Cited 2022.\u00a0\u3008https:\/\/www.auanet.org\/about-us\/bcg-shortage-info\u3009 accessed 11\/22\/2022."},{"key":"10.1016\/j.urology.2023.02.044_bib13","first-page":"1401","article-title":"Ensuring access to injectable generic drugs - the case of intravesical BCG for bladder cancer","volume":"376","author":"Davies","year":"2017","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"key":"10.1016\/j.urology.2023.02.044_bib14","unstructured":"Rural-Urban Continuum Codes: US Department of Agriculture. 2013. \u3008https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes.aspx\u3009 accessed 11\/22\/2022."},{"key":"10.1016\/j.urology.2023.02.044_bib15","doi-asserted-by":"crossref","unstructured":"Lobo N, Bree KK, Hensley PJ, Nogueras\u2010Gonzalez GM, Abraham P, Navai N, Dinney CP, Kamat AM. Reduced\u2010dose bacillus Calmette\u2010Gu\u00e9rin (BCG) in an era of BCG shortage: real\u2010world experience from a tertiary cancer centre. BJU international. 2022 Sep;130(3):323-30","DOI":"10.1111\/bju.15661"},{"key":"10.1016\/j.urology.2023.02.044_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.urology.2020.08.004","article-title":"Contemporary treatment patterns for non-muscle-invasive bladder cancer: has the use of radical cystectomy changed in the BCG shortage era?","volume":"147","author":"Tully","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.02.044_bib17","first-page":"111","article-title":"Recurrence rate and cost consequence of the shortage of Bacillus Calmette-Gu\u00e9rin connaught strain for bladder cancer patients","volume":"7","author":"Ourfali","year":"2021","journal-title":"Eur\u00a0Urol\u00a0Focus"},{"key":"10.1016\/j.urology.2023.02.044_bib18","first-page":"902","article-title":"Multi-institution evaluation of sequential gemcitabine and docetaxel as rescue therapy for nonmuscle invasive bladder cancer","volume":"203","author":"Steinberg","year":"2020","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2023.02.044_bib19","first-page":"589","article-title":"Sequential intravesical gemcitabine and docetaxel for Bacillus Calmette-Gu\u00e9rin-Na\u00efve high-risk nonmuscle-invasive bladder cancer","volume":"208","author":"McElree","year":"2022","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2023.02.044_bib20","unstructured":"Group ECO. Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE).\u00a02022.\u00a0\u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05538663\u3009 accessed 11\/22\/2022."},{"key":"10.1016\/j.urology.2023.02.044_bib21","unstructured":"S1602, A Phase III randomized trial to evaluate the influence of BCG strain differences and T cell priming with intradermal BCG before intravesical therapy for BCG-naive high-grade non-muscle invasive bladder cancer: clinicaltrials.gov.\u00a02017.\u00a0\u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03091660\u3009."}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429523002674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429523002674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:15:21Z","timestamp":1726618521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429523002674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":21,"alternative-id":["S0090429523002674"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2023.02.044","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin\u00a0Drug Shortage","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2023.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}